Keeping Current
Clinical Perspectives on the Use of PI3K/AKT Pathway Inhibitors in the Management of HR+/HER2− Metastatic Breast Cancer
- Autor: Vários
- Narrador: Vários
- Editora: Podcast
- Duração: 0:36:15
- Mais informações
Informações:
Sinopse
Where do PI3K/AKT pathway inhibitors fit in the modern treatment landscape of breast cancer? Credit available for this activity expires: 3/19/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/clinical-perspectives-use-pi3k-akt-pathway-inhibitors-2026a100087h?ecd=bdc_podcast_libsyn_mscpedu
